Skip to content

Clinical trials

Cholangiocarcinoma trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Country / region: Belgium Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20143
20152
20161
20175
20183
20195
20201
20212
20223
20233
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated10
Active, not recruiting7
Recruiting3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation3
QED Therapeutics, a BridgeBio company2
University Hospital, Ghent2
AbbVie1
American University of Beirut Medical Center1
Amgen1
AstraZeneca1
Basilea Pharmaceutica1
Bayer1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma33
Pancreatic Neoplasms7
Bile Duct Neoplasms6
Carcinoma, Hepatocellular6
Biliary Tract Neoplasms5
Carcinoma, Non-Small-Cell Lung5
Colorectal Neoplasms4
Gallbladder Neoplasms4
Ovarian Neoplasms4
Endometrial Neoplasms3

Trials

Showing 51 to 33 of 33. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.